A Randomised Comparison of Bicalutamide ('Casodex') 150 mg versus Placebo as Immediate Therapy Either Alone or as Adjuvant to Standard Care for Early Non-Metastatic Prostate Cancer - First Report from the Scandinavian Prostatic Cancer Group Study No. 6

By Iversen P.   Tammela T.L.J.   Vaage S.   Lukkarinen O.   Lodding P.   Bull-Njaa T.   Viitanen J.   Hoisaeter P.   Lundmo P.   Rasmussen F.   Johansson J.-E.   Persson B.-E.   Carroll K.   Scandinavian Prostatic Cancer Group SPCG  

European Urology, Vol. 42, Iss. 3, 2002-09 ,pp. : 204-211

Elsevier

Access to resources Recommend Favorite

Immediate Therapy in Early Prostate Cancer: Results from the Bicalutamide ('Casodex') EPC Programme

By Wirth M.   Iversen P.   McLeod D.   See W.  

European Urology Supplements, Vol. 1, Iss. 7, 2002-10 ,pp. : 20-25

Elsevier

Access to resources Recommend Favorite

Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years

By Iversen P.   Tyrrell C.J.   Kaisary A.V.   Anderson J.B.   Baert L.   Tammela T.   Chamberlain M.   Carroll K.   Gotting-Smith K.   Blackledge G.R.P.  

Urology, Vol. 51, Iss. 3, 1998-03 ,pp. : 389-396

Elsevier

Access to resources Recommend Favorite

Rapid disease progression after the administration of bicalutamide in patients with metastatic prostate cancer

By Laufer M.   Sinibaldi V.J.   Carducci M.A.   Eisenberger M.A.  

Urology, Vol. 54, Iss. 4, 1999-10 ,pp. : 745-745

Elsevier

Access to resources Recommend Favorite

Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease

By D'Amico A.V.   Schnall M.   Whittington R.   Malkowicz S.B.   Schultz D.   Tomaszewski J.E.   Wein A.  

Urology, Vol. 51, Iss. 3, 1998-03 ,pp. : 449-454

Elsevier

Access to resources Recommend Favorite